Clinical Trial Update: VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil [Phase 3]

View source ↗

Summary

Phase 3 trial update for VALORY study assessing valsartan/hydrochlorizide in patients with hypertension who do not respond to olmesartan medoxomil; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Valsartan/Hydrochlorizide (Valsartan/Hydrochlorizide)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED